We are live on ! Find out more
MC

Marcus Capital Portfolio holdings

AUM $34.3M
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+30.44%
3 Year Est. Return
+101.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$9.64M
Cap. Flow
+$1.13M
Cap. Flow %
0.96%
Top 10 Hldgs %
36.63%
Holding
53
New
4
Increased
18
Reduced
21
Closed
3

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.96M
2
AKAO
Achaogen Inc
AKAO
+$1.86M
3
ANF icon
Abercrombie & Fitch
ANF
+$1.85M
4
P
Everpure Inc
P
+$985K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$961K

Top Sells

Rank Stock Value
1
ACHN
Achillion Pharmaceuticals
ACHN
+$1.75M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.08M
3
WFM
Whole Foods Market Inc
WFM
+$1.01M
4
ANET icon
Arista Networks
ANET
+$750K
5
FUEL
Rocket Fuel Inc.
FUEL
+$574K

Sector Composition

Rank Sector Weight
1 Technology 25.76%
2 Consumer Discretionary 24.2%
3 Financials 13.57%
4 Healthcare 12.7%
5 Consumer Staples 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
51
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-69,400
Closed -$1.75M
FUEL
52
DELISTED
Rocket Fuel Inc.
FUEL
– –
-107,121
Closed -$574K
WFM
53
DELISTED
Whole Foods Market Inc
WFM
– –
-34,075
Closed -$1.01M
1 2
3

Similar funds

PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RIA
Rocaton Investment Advisors Norwalk, Connecticut $36.6M AUM 10.31% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
IP
Ironsides Partners Boston, Massachusetts $27.7M AUM 1.11% 1-Year Est. Return
DCM
Dearborn Capital Management Chicago, Illinois $41.6M AUM 2.79% 1-Year Est. Return
PA
Pastel & Associes Paris, France $43.8M AUM 18.14% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return

Marcus Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Marcus Capital held 53 positions worth $117M, up 9% from $107M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Marcus Capital's Q2 2017 filing shows 4 new, 18 increased, 21 reduced and 3 closed positions. Its largest new stake was Qualcomm: 35,050 shares worth $1.94M. The largest sale was Achillion Pharmaceuticals, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marcus Capital's largest Q2 2017 buy was Qualcomm: 35,050 shares worth $1.94M.
  • Marcus Capital added most to Everpure Inc in Q2 2017, an estimated $985K increase.
  • Marcus Capital's biggest Q2 2017 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $1.08M.
  • Marcus Capital fully exited Achillion Pharmaceuticals in Q2 2017, selling an estimated $1.75M.
  • Marcus Capital's ten largest holdings make up 37% of its $117M portfolio in Q2 2017.
  • Marcus Capital opened 4 new positions and closed 3 in Q2 2017.
  • Marcus Capital's portfolio value rose 9% quarter-over-quarter to $117M.

Based on Marcus Capital's 13F filing for Q2 2017, filed 10 Aug 2017.